Ampicillin-Sulbactam Dosing in Infants
For infants ≥1 year old, administer ampicillin-sulbactam 300 mg/kg/day (total drug: 200 mg ampicillin + 100 mg sulbactam per kg/day) divided every 6 hours via IV infusion, with a maximum sulbactam dose of 4 grams per day. 1
Age-Specific Dosing Recommendations
Infants 8-21 Days Old
For febrile infants in this age group, ampicillin-sulbactam is NOT the recommended first-line empiric therapy. Instead, use:
- Ampicillin alone (150 mg/kg/day divided every 8 hours) PLUS either ceftazidime or gentamicin 2
- For bacterial meningitis: Ampicillin 300 mg/kg/day divided every 6 hours plus ceftazidime 2
The rationale is that this age group requires broader coverage for Group B Streptococcus, Listeria, and early-onset sepsis pathogens, which necessitates ampicillin combined with an aminoglycoside or third-generation cephalosporin rather than the beta-lactamase inhibitor combination.
Infants 22-60 Days Old
Similarly, ampicillin-sulbactam is not recommended as first-line therapy. Use ceftriaxone 50 mg/kg once daily for empiric coverage 2.
Infants ≥1 Year Old (FDA-Approved Dosing)
Standard dosing: 300 mg/kg/day (200 mg ampicillin + 100 mg sulbactam per kg/day) divided every 6 hours via IV infusion 1
- Maximum sulbactam dose: 4 grams per day
- Infants weighing ≥40 kg should receive adult dosing (1.5-3 g every 6 hours)
- IV therapy should not routinely exceed 14 days 1
Renal Dose Adjustments
Ampicillin and sulbactam are eliminated renally with similar kinetics, so the 2:1 ratio remains constant regardless of renal function 3. Adjust frequency based on creatinine clearance:
- CrCl ≥30 mL/min/1.73m²: Standard dosing every 6-8 hours
- CrCl 15-29 mL/min/1.73m²: Every 12 hours
- CrCl 5-14 mL/min/1.73m²: Every 24 hours 1
Important Caveat for Neonates
Neonates have immature renal function with prolonged elimination half-lives (ampicillin: 9.4 hours; sulbactam: 7.9 hours versus <1 hour in older children) 4. For neonates requiring ampicillin-sulbactam, use 50 mg/kg of each drug every 12 hours 4, though this is off-label and should only be used when specifically indicated (not for routine empiric fever workup).
Pharmacokinetic Considerations
The pharmacokinetics in children 1-12 years are comparable to adults:
- Mean clearance: 4.76 mL/min/kg (ampicillin), 4.95 mL/min/kg (sulbactam)
- Half-life: 0.77 hours (ampicillin), 0.81 hours (sulbactam)
- Neither dose nor gender significantly affects PK 5
Age is not a statistically significant covariate in PK for children ≥1 year 6, supporting uniform weight-based dosing across pediatric age groups.
Administration Details
- IV infusion over 15-30 minutes is preferred 1
- Can give as slow IV injection over 10-15 minutes
- IM administration safety/efficacy not established in pediatrics 1
- Dilute in 50-100 mL compatible diluent for infusion 1
Critical Clinical Pitfall
Do NOT use ampicillin-sulbactam as empiric monotherapy for febrile infants <60 days old. The 2021 AAP guidelines clearly specify ampicillin (without sulbactam) combined with other agents for this population 2. The sulbactam component does not add benefit for the typical pathogens (GBS, Listeria, E. coli) in young febrile infants and may provide false reassurance about coverage.